Surmodics Reports First Quarter Fiscal 2019 Results

Go back to Surmodics Reports First Quarter Fiscal 2019 Results

SurModics (SRDX) PT Lowered to $69 at Needham & Company

January 31, 2019 8:26 AM EST

Needham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $69.00 (from $74.00) while maintaining a Buy rating.

Matson commented, "RDX beat consensus F1Q19 revenue and EPS estimates. Management raised the lower end of its FY19 revenue guidance and narrowed... More

SurModics (SRDX) Reports Q1 EPS of $0.12, Revenues Beat; Raises FY19 EPS/Revenue Mid-Point Guidance Above Consensus

January 30, 2019 4:31 PM EST

SurModics (NASDAQ: SRDX) reported Q1 EPS of $0.12, versus $0.10 reported last year. Revenue for the quarter came in at $22.2 million versus the consensus estimate of $20.18 million.

Revenue of $22.2 million, an increase of 31% year-over-yearGAAP EPS of $0.09, non-GAAP EPS of $0.12Updating fiscal 2019... More